Sandra Coral

3.1k total citations
53 papers, 2.3k citations indexed

About

Sandra Coral is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sandra Coral has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 33 papers in Immunology and 12 papers in Oncology. Recurrent topics in Sandra Coral's work include Immunotherapy and Immune Responses (26 papers), Epigenetics and DNA Methylation (24 papers) and Histone Deacetylase Inhibitors Research (12 papers). Sandra Coral is often cited by papers focused on Immunotherapy and Immune Responses (26 papers), Epigenetics and DNA Methylation (24 papers) and Histone Deacetylase Inhibitors Research (12 papers). Sandra Coral collaborates with scholars based in Italy, United States and Malaysia. Sandra Coral's co-authors include Michele Maio, Luca Sigalotti, Maresa Altomonte, Elisabetta Fratta, Francesca Colizzi, Alessia Covre, Ester Fonsatti, Riccardo Danielli, Giulia Parisi and Hugues J. M. Nicolay and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sandra Coral

52 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Coral Italy	25	1.6k	1.1k	691	270	195	53	2.3k
Luca Sigalotti Italy	28	1.7k 1.1×	1.1k 1.1×	813 1.2×	294 1.1×	207 1.1×	61	2.6k
Luigi Scotto United States	30	1.5k 1.0×	1.1k 1.0×	642 0.9×	280 1.0×	121 0.6×	82	2.8k
Francesca Colizzi Italy	23	1.3k 0.8×	881 0.8×	537 0.8×	216 0.8×	139 0.7×	40	1.8k
Marialuisa Sensi Italy	27	1.4k 0.9×	1.8k 1.7×	1.1k 1.7×	287 1.1×	147 0.8×	92	2.9k
Viia Valge-Archer United Kingdom	19	1.1k 0.7×	1.2k 1.1×	1.0k 1.5×	373 1.4×	130 0.7×	27	2.4k
Henry Koon United States	25	1.4k 0.9×	910 0.9×	1.3k 1.9×	240 0.9×	282 1.4×	59	2.9k
Maciej Kmieciak United States	24	849 0.5×	876 0.8×	971 1.4×	225 0.8×	149 0.8×	66	2.0k
Karen Clise-Dwyer United States	23	795 0.5×	1.1k 1.0×	781 1.1×	359 1.3×	94 0.5×	54	2.2k
Habib Fakhrai United States	19	990 0.6×	861 0.8×	1.1k 1.6×	140 0.5×	190 1.0×	35	2.1k
Barbara J. Schiemann United States	15	685 0.4×	807 0.8×	484 0.7×	368 1.4×	125 0.6×	17	1.8k

Countries citing papers authored by Sandra Coral

Since Specialization

Citations

This map shows the geographic impact of Sandra Coral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Coral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Coral more than expected).

Fields of papers citing papers by Sandra Coral

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Coral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Coral. The network helps show where Sandra Coral may publish in the future.

Co-authorship network of co-authors of Sandra Coral

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Coral. A scholar is included among the top collaborators of Sandra Coral based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Coral. Sandra Coral is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caruso, Francesca Pia, Teresa Noviello, Roberta Mortarini, et al.. (2025). DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy. Journal of Experimental & Clinical Cancer Research. 44(1). 58–58. 1 indexed citations

Caruso, Francesca Pia, Teresa Noviello, Roberta Mortarini, et al.. (2024). Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches. Journal of Translational Medicine. 22(1). 223–223. 8 indexed citations

Noviello, Teresa, Anna Maria Di Giacomo, Francesca Pia Caruso, et al.. (2023). Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. Nature Communications. 14(1). 5914–5914. 18 indexed citations

Sabato, Claudia, Teresa Noviello, Alessia Covre, et al.. (2022). A novel microRNA signature for the detection of melanoma by liquid biopsy. Journal of Translational Medicine. 20(1). 469–469. 16 indexed citations

Fazio, Carolina, Ornella Cutaia, Anna Maria Di Giacomo, et al.. (2021). Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy. Epigenomes. 5(4). 27–27. 5 indexed citations

Fazio, Carolina, Alessia Covre, Ornella Cutaia, et al.. (2018). Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy. Frontiers in Pharmacology. 9. 1443–1443. 19 indexed citations

Sigalotti, Luca, Elisabetta Fratta, Sandra Coral, & Michele Maio. (2014). Epigenetic drugs as immunomodulators for combination therapies in solid tumors. Pharmacology & Therapeutics. 142(3). 339–350. 78 indexed citations

Sigalotti, Luca, Elisabetta Fratta, Giulia Parisi, Sandra Coral, & Michele Maio. (2013). Epigenetic Markers of Prognosis in Melanoma. Methods in molecular biology. 1102. 481–499. 8 indexed citations

Sigalotti, Luca, Alessia Covre, Elisabetta Fratta, et al.. (2012). Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients. Journal of Translational Medicine. 10(1). 185–185. 43 indexed citations

10.

Coral, Sandra, Giulia Parisi, Hugues J. M. Nicolay, et al.. (2012). Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide. Cancer Immunology Immunotherapy. 62(3). 605–614. 59 indexed citations

11.

Fratta, Elisabetta, Luca Sigalotti, Francesca Colizzi, et al.. (2010). Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma. Journal of Cellular Physiology. 223(2). 352–358. 21 indexed citations

12.

Sigalotti, Luca, Alessia Covre, Elisabetta Fratta, et al.. (2010). Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies. Journal of Translational Medicine. 8(1). 56–56. 92 indexed citations

13.

Sigalotti, Luca, Elisabetta Fratta, Sandra Coral, et al.. (2007). Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications. Journal of Cellular Physiology. 212(2). 330–344. 113 indexed citations

14.

Sigalotti, Luca, Sandra Coral, Maresa Altomonte, et al.. (2002). Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications. British Journal of Cancer. 86(6). 979–982. 71 indexed citations

15.

Fonsatti, Ester, Luigi Del Vecchio, Maresa Altomonte, et al.. (2001). Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. Journal of Cellular Physiology. 188(1). 1–7. 151 indexed citations

16.

Gasparollo, Aldo, Sandra Coral, Marina Ciullo, et al.. (2001). Unbalanced expression of HLA-A and -B antigens: A specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-?. International Journal of Cancer. 91(4). 500–507. 10 indexed citations

17.

Coral, Sandra, Ester Fonsatti, Luca Sigalotti, et al.. (2000). Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement. Journal of Cellular Physiology. 185(3). 317–323. 22 indexed citations

18.

Coral, Sandra, Luca Sigalotti, Aldo Gasparollo, et al.. (1999). Prolonged Upregulation of the Expression of HLA Class I Antigens and Co stimulatory Molecules on Melanoma Cells Treated with 5-aza-2??-deoxycytidine (5-AZA-CdR). Journal of Immunotherapy. 22(1). 16–24. 110 indexed citations

19.

Fonsatti, Ester, Maresa Altomonte, Sandra Coral, et al.. (1997). Tumour-derived interleukin 1α (IL-1α) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells. British Journal of Cancer. 76(10). 1255–1261. 22 indexed citations

20.

Braşoveanu, Lorelei Irina, Maresa Altomonte, Annunziata Gloghini, et al.. (1995). Expression of protectin (CD59) in human melanoma and its functional role in cell‐ and complement‐mediated cytotoxicity. International Journal of Cancer. 61(4). 548–556. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact